Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
News Medical on MSN13d
Reprogramming T cells to overcome tumor challengesSolid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and ...
Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way ...
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...
Circadian rhythms are endogenous time-keeping mechanisms that regulate physiological processes in response to external ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback